Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Green light for the marketing of the first superconductive cyclotron for hadrontherapy

24.07.2006
The agreement between the Italian National Institute for Nuclear Physics and the Belgian firm Iba for the marketing, in biomedical field, of the first superconductive cyclotron producing protons and carbon ions as well, has been made official today. The innovative project, that will developed by the Infn Southern National Laboratories and realized with the contribution of the Iba specific twenty-year experience in the field of cyclotrons for medical applications, was conceived for the hospital centres of oncological hadrontherapy.

Hadrontherapy is one of the most refined radiotherapic technique for tumours treatment. It uses hadrons, that is to say charged particles made up from quarks, as protons and ions. These particles, contrary to what occurs in radiotherapy, can be directed with precision against the tumour mass, with minimum risks to hit vital organs and surrounding healthy tissues. In particular ions have a higher radiobiological effect: they can hit in fact deep tumours, for this reason they are particular indicated for radioresistent tumours, such as cerebral tumours, the ones of the head-neck area and lung and pancreas carcinoma. Therapy with protons is instead indicated for tumours located near organs at risk, such as eye, head base, or along the backbone, because they allow to direct the beam form in a more refined way.

Up today the only instruments able to produce protons and ions as well for hadrontherapy are synchrotrons: accelerators machines, much more complex, bulkier and expensive than cyclotrons. A synchrotron consists indeed of a ring with a diameter of at least 25 metres, while a cyclotron is a compact instrument with a diameter of 5 metres and with a considerably lower cost. In the context of its studies for the development of new syncrotrons, Infn has worked for the development of a multiparticle cyclotron, able to provide protons and carbon ions with the energy required for hadrontherapic treatments. "The new cyclotron offers a great technological advantage. Thanks to it, for the first time a doctor will have the opportunity to choose to produce ions or protons, according to the kind of tumour, with a compact, easily to manage and decidedly cheaper instrument than the traditional one. With the ions produced by this new machine, it will possible to treat tumours at a maximum depth of 18 centimetres", explain Giacomo Cuttone and Luciano Calabretta of Infn Southern National Laboratories.

There are in the world several centres for hadrontherapy, most of all in Japan and in the United States. In Italy there is the sperimental project Catana (Hadrontherapy Centre and Advanced Nuclear Applications). Started at the Infn Southern National Laboratories in cooperation with Catania University, Catana is dedicated to the treatment with protons of eye tumour (up today the treated patients are 112). Concerning hadrontherapy with ions, there are in Europe two structures under construction: one is the Heidelberg University clinic, in Germany, the other is the National Centre of Hadrontherapy that will rise in Pavia, from the collaboration between the Cnao foundation and Infn.

The new cyclotron developed by Infn and realized by Iba will be able to enrich the therapeutic power of hadrontherapy centres.

Barbara Gallavotti | alfa
Further information:
http://www.presid.infn.it

More articles from Physics and Astronomy:

nachricht Comet or asteroid? Hubble discovers that a unique object is a binary
21.09.2017 | NASA/Goddard Space Flight Center

nachricht First users at European XFEL
21.09.2017 | European XFEL GmbH

All articles from Physics and Astronomy >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>